Diagnostic stigmas of alcoholic liver disease
https://doi.org/10.51523/2708-6011.2023-20-2-01
Abstract
Alcohol is a toxic substance that is associated with a spectrum of liver damage, including simple steatosis or fatty- degeneration of liver, alcoholic hepatitis, fibrosis, and cirrhosis. Alcoholic liver disease (ALD) is the general term used for this spectrum of alcohol-related liver damage. Excessive or harmful alcohol use is among the top five risk factors for death and disability worldwide, causing 2.5 million deaths and 69.4 million annual disability-adjusted life years. The diagnosis of ABP can usually be made on the basis of anamnesis, clinical and laboratory findings. However, the diagnosis of ABP can be clinically challenging because there is no a single diagnostic test to confirm the diagnosis, and patients may not report the extent of their alcohol use.
About the Authors
O. S. Pershenkova
Gomel State Medical University
Belarus
Belarus
Olga S. Pershenkova, Assistant Lecturer at the Department of General and Clinical Pharmacology
Gomel
E. I. Mikhailova
Gomel State Medical University
Belarus
Belarus
Elena I. Mikhailova, Doctor of Medical Sciences, Professor at the Department of General and Clinical Pharmacology
Gomel
References
1. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018 Feb;113(2):175-194. DOI: https://doi.org/10.1038/ajg.2017.469
2. Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, et al. Alcoholic liver disease. Nat Rev Dis Primers. 2018 Aug 16;4(1):16. DOI: https://doi.org/10.1038/s41572-018-0014-7
3. Osna NA, Donohue TM Jr, Kharbanda KK. Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res. 2017;38(2):147-161.
4. Medvedev A.S. Monitoring of situation and social damage connected with alcohol: methodical guide. Minsk: Kovcheg; 2013. 222 p. (in Russ.).
5. Di Sarno R, Brigida A, Caprio GG, Ciardiello D, Dallio M, Sangineto M, et al. Critical review on the use and abuse of alcohol. When the dose makes the difference. Minerva Med. 2020 Aug;111(4):344-353.
6. Holleck JL, Merchant N, Gunderson CG. SymptomTriggered Therapy for Alcohol Withdrawal Syndrome: a Systematic Review and Meta-analysis of Randomized Controlled Trials. J Gen Intern Med. 2019 Jun;34(6):1018-1024.
7. Grishenkova LN. Biomarkers of alcohol abuse: a role in the diagnosis and retrospective evaluation of chronic alcohol intoxication. Laboratory diagnostics. Eastern Europe. 2021;10(2):217-245. (in Russ.).
8. Walsh K, Alexander G Alcoholic liver disease. Postgraduate Medical Journal. 2000;76:280-286.
9. Sand J, Välikoski A, Nordback I. Alcohol consumption in the country and hospitalizations for acute alcohol pancreatitis and liver cirrhosis during a 20-year period. Alcohol Alcohol. 2009 MayJun;44(3):321-325. DOI: https://doi.org/10.1093/alcalc/agn121
10. Razvodovskij YuE, Nemcov AV. Contribution of alcohol into gender differences of the level of general mortality in Russia and Belarus. Questions of narcology. 2020;(6):60-69. (in Russ.).
11. Al’tshuler VB. Alcoholism. M.: GEOTAR-Media; 2010. 264 p. (in Russ.).
12. Higgins-Biddle JC, Babor TF. A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: Past issues and future directions. Am J Drug Alcohol Abuse. 2018;44(6):578-586. DOI: https://doi.org//10.1080/00952990.2018.1456545
13. MacKenzie DM, Langa A, Brown TM. Identifying hazardous or harmful alcohol use in medical admissions: a comparison of AUDIT, CAGE and brief MAST. Alcohol and Alcoholism.1996;31(6):591-599.
14. Delaney KE, et al. Inconsistencies between alcohol screening results based on AUDIT-C scores and reported drinking on the AUDIT-C questions: prevalence in two US national samples. Addict Sci Clin Pract. 2014; 9(2):110-114. DOI: https://doi.org//10.1186/1940-0640-9-2
15. Zamora-Rodríguez FJ, Tolosa-Gutiérrez L, SánchezAutet M, Arranz B, Gónzález-Martínez I, Benítez-Vega C, et al. Detection of alcohol use disorders using the camouflaged CAGE questionnaire in three population groups. Adicciones. 2021 Mar 31;33(2):121-136. DOI: https://doi.org//10.20882/adicciones.1287
16. Israelsen M, Juel HB, Detlefsen S, Madsen BS, Rasmussen DN, et al. Metabolic and genetic risk factors are the strongest predictors of severity of alcohol-related liver fibrosis. Clinical Gastroenterology and Hepatology. 2022;20(8):1784-1794.e9. DOI: https://doi.org/10.1016/j.cgh.2020.11.038
17. Singal AK, Mathurin P. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. JAMA. 2021 Jul 13;326(2):165-176. DOI: https://doi.org/10.1001/jama.2021.7683
18. Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci. 2021 May 13;22(10):5170. DOI: https://doi.org/10.3390/ijms22105170
19. Rehm J. The risks associated with alcohol use and alcoholism. Alcohol Res Health. 2011;34(2):135-143.
20. Pronko PS. Biomarkers in the diagnosis of alcoholism. The lead the national academy of sciences. 2009;(2):103-116. (in Russ.).
21. Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, et al. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. Int J Mol Sci. 2019 Jun 2;20(11):2712. DOI: https://doi.org/10.3390/ijms20112712
22. Amieva-Balmori M, Mejia-Loza SM, Ramos-González R, Zamarripa-Dorsey F, García-Ruiz E, Pérez Y López N, et al. Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best? World J Hepatol. 2015 Aug 18;7(17):2119-2126. DOI: https://doi.org/10.4254/wjh.v7.i17.2119
23. W. Dunn LH, Jamil LS, Brown RH, Wiesner WR, Kim KV, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41:353-358.
24. Hyun J, Han J, Lee C, Yoon M, Jung Y. Pathophysiological Aspects of Alcohol Metabolism in the Liver. Int J Mol Sci. 2021 May 27;22(11):5717. DOI: https://doi.org/10.3390/ijms22115717
25. Cai C, Song X, Chen X, Zhou W, Jin Q, Chen S, Ji F. Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis. Can J Gastroenterol Hepatol. 2021 Jan 20; 2021:8859338. DOI: https://doi.org/10.1155/2021/8859338
26. Dulai PS, Sirlin CB, Loomba R. MRI and MRE for noninvasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice. J Hepatol. 2016;65(5):1006-1016.
27. Nguyen-Khac E, Houchi H, Dreher ML, et al. Is PNPLA3 polymorphism involved in severe acute alcoholic hepatitis. Hepatology. 2011;54:976A.
28. Schwantes-An TH, Darlay R, Mathurin P, Masson S, Liangpunsakul S, Mueller S, et al. Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors. Hepatology. 2021 May;73(5):1920-1931. DOI: https://doi.org/10.1002/hep.31535
29. Barrio P, Wurst FM, Gual A. New Alcohol Biomarkers. New challenges. Alcohol Alcohol. 2018 Nov 1;53(6):762-763. DOI: https://doi.org/10.1093/alcalc/agy064
30. Stickel F, Hampe J. Genetic determinants of alcoholic liver disease. Gut. 2012;61:150-159.
Review
For citations:
Pershenkova O.S., Mikhailova E.I. Diagnostic stigmas of alcoholic liver disease. Health and Ecology Issues. 2023;20(2):7-13. (In Russ.) https://doi.org/10.51523/2708-6011.2023-20-2-01
Views: 496
Email this article 